seribantumab
elevation oncology
['crestone', 'seribantumab', 'solid tumor']
#aacr23 | section 47 | tuesday
ct229 - crestone: a phase 2 study of seribantumab in adult patients with neuregulin-1 (nrg1) fusion positive locally advanced or metastatic solid tumors
jessica lin, md ( ) 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.